Skip to main content
SpringerLink
Log in

Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

Dofetilide, an IKr blocker has been demonstrated to be effective in terminating persistent atrial fibrillation and flutter (AF/AFL), and in maintaining sinus rhythm after direct current cardioversion (CV). It is not known, however, whether pharmacological conversion with dofetilide predicts maintenance of sinus rhythm. In addition, there is limited information comparing the efficacy of dofetilide in persistent versus paroxysmal AF/AFL.

Methods and Results

Eighty consecutive patients with AF/AFL (51 persistent, 29 paroxysmal) admitted for initiation of dofetilide were studied. Termination of persistent AF/AFL occurred in 61% of patients while 39% required CV. After 21 ± 19 months of follow-up, 37% of patients with persistent AF/AFL were free of recurrence. Acute conversion with dofetilide did not predict long term efficacy. Dofetilide was more effective in maintaining sinus rhythm in patients with AFL (65%) than in those with AF (25%) (p < 0.05). Dofetilide was more likely to maintain sinus rhythm in patients with persistent than paroxysmal AF/AFL (37 vs. 14%; p < 0.05). Torsades de Pointes developed in two patients despite careful dosing and monitoring of QT changes.

Conclusions

Dofetilide is more effective in patients with persistent than in those with paroxysmal AF/AFL. Importantly, short-term response does not necessarily predict long-term efficacy. Significant proarrhythmia can occur even with careful in-hospital monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fuster, V., Ryden, L. E., Cannom, D. S., et al. (2006). ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Circulation, 114, e257–e354.

    Article  PubMed  Google Scholar 

  2. Gwilt, M., Arrowsmith, J. E., Blackburn, K. J., et al. (1991). UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. The Journal of Pharmacology and Experimental Therapeutics, 256, 318–324.

    PubMed  CAS  Google Scholar 

  3. Mounsey, J. P., & DiMarco, J. P. (2000). Cardiovascular drugs. Dofetilide. Circulation, 102, 2665–2670.

    PubMed  CAS  Google Scholar 

  4. Roukoz, H., & Saliba, W. (2007). Dofetilide: a new class III antiarrhythmic agent. Expert Review of Cardiovascular Therapy, 5(1), 9–19.

    Article  PubMed  CAS  Google Scholar 

  5. Greenbaum, R. A. (1999). Meeting highlights: highlights of the 71st Scientific Sessions of the American Heart Association. The EMERALD trial. Circulation, 99, 2486–2491.

    Google Scholar 

  6. Singh, S., Zoble, R. G., Yellen, L., et al. (2000). Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on defetilide (SAFIRE-D) study. Circulation, 102, 2385–2390.

    PubMed  CAS  Google Scholar 

  7. Torp-Pedersen, C., Moller, M., Bloch-Thomsen, P. E., et al. (1999). Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. The New England Journal of Medicine, 341, 857–865.

    Article  PubMed  CAS  Google Scholar 

  8. Kober, L., Bloch Thompsen, P. E., Moller, M., et al. (2000). Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction: a randomized trial. Lancet, 356, 2052–2058.

    Article  PubMed  CAS  Google Scholar 

  9. Pedersen, O. D., Bagger, H., Keller, N., & Marchant, B. (2001). kober l, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation–flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation, 104, 292–296.

    PubMed  CAS  Google Scholar 

  10. Prystowsky, E. N., Freeland, S., Branyas, N. A., et al. (2003). Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14, S287–S290.

    Article  PubMed  Google Scholar 

  11. Mykytsey, A., Bauman, J. L., Razminia, M., et al. (2007). Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. Journal of Cardiovascular Pharmacology and Therapeutics, 12, 36–43.

    Article  PubMed  CAS  Google Scholar 

  12. Cotiga, D., Arshad, A., Aziz, E., et al. (2007). Acute conversion of persistent atrial fibrillation during dofetilide initiation. Pacing and Clinical Electrophysiology, 30, 1527–1530.

    PubMed  Google Scholar 

  13. Feld, G. K., & Cha, Y. (1997). Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide in an experimental canine model of pacing-induced atrial fibrillation. Journal of Cardiovascular Pharmacology and Therapeutics, 2(3), 195–203.

    Article  PubMed  CAS  Google Scholar 

  14. Tai, C. T., & Chen, S. A. (2001). Mechanisms of antiarrhythmic drug action on termination of atrial flutter. Pacing and Clinical Electrophysiology, 24, 824–834.

    Article  PubMed  CAS  Google Scholar 

  15. Falk, R. H., Pollak, A., Singh, S. N., et al. (1997). Intravenous dofetilide a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. Journal of the American College of Cardiology, 29(2), 385–390.

    Article  PubMed  CAS  Google Scholar 

  16. Stambler, B. S., Wood, M. A., & Ellenbogen, K. A. (1997). Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Electrophysiological determinants of enhanced conversion efficacy. Circulation, 96, 4298–4306.

    PubMed  CAS  Google Scholar 

  17. Wirth, K. J., & Knobloch, K. (2001). Differential effects of dofetilide, amiodarone, and class Ic drugs on left and right atrial refractoriness and left atrial vulnerability in pigs. Naunyn-Schmiedeberg’s Archives of Pharmacology, 363, 166–174.

    Article  PubMed  CAS  Google Scholar 

  18. Knobloch, K., Brendel, J., Peukert, S., et al. (2002). Electrophysiological and antiarrhythmic effects of the novel Ikur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the IKr blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Naunyn-Schmiedeberg’s Archives of Pharmacology, 366, 482–487.

    Article  PubMed  CAS  Google Scholar 

  19. Waldo, A. L. (2002). Mechanisms of atrial flutter and atrial fibrillation: distinct entities or two sides of a coin. Cardiovascular Research, 54, 216–229.

    Article  Google Scholar 

  20. Waldo, A. L., & Feld, G. K. (2008). Inter-relationships of atrial fibrillation and atrial flutter. Journal of the American College of Cardiology, 51, 779–786.

    Article  PubMed  Google Scholar 

  21. Cappato, R., Calkins, H., Chen, S. A., et al. (2005). Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation, 111, 1100–1105.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Penn State Heart and Vascular Institute, Milton S. Hershey Medical Center, Penn State University, 500 University Drive, P.O. Box 850, Hershey, PA, 17033-0850, USA

    Javier E. Banchs, Deborah L. Wolbrette, Soraya M. Samii, Erica D. Penny-Peterson, Parag P. Patel, Mario D. Gonzalez & Gerald V. Naccarelli

  2. Department of Pharmacy, Penn State University, Hershey, PA, USA

    Sallie K. Young

Authors
  1. Javier E. Banchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deborah L. Wolbrette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Soraya M. Samii
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erica D. Penny-Peterson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Parag P. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sallie K. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mario D. Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gerald V. Naccarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javier E. Banchs.

Additional information

Dr. Banchs and Dr. Wolbrette contributed equally to this study.

Presented in abstract form at the XIII World Congress on Cardiac Pacing and Electrophysiology; December 3, 2007; Rome and published in abstract form (Giornale Italiano di Aritmologia e Cardiostimolazione 2007;10(3):26).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banchs, J.E., Wolbrette, D.L., Samii, S.M. et al. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. J Interv Card Electrophysiol 23, 111–115 (2008). https://doi.org/10.1007/s10840-008-9290-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-008-9290-6

Keywords

Search

Navigation